"10.1371_journal.pone.0091857","plos one","2014-03-14T00:00:00Z","Yoshifumi Kotani; Jun Kunisawa; Yuji Suzuki; Ikutaro Sato; Takao Saito; Masamichi Toba; Noriyuki Kohda; Hiroshi Kiyono","Otsu Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Shiga, Japan; Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Medical Genome Science, Graduate School of Frontier Science, The University of Tokyo, Chiba, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Tokyo, Japan; Laboratory of Vaccine Materials, National Institute of Biomedical Innovation, Osaka, Japan","Conceived and designed the experiments: YK JK TS MT NK HK. Performed the experiments: YK JK YS IS. Analyzed the data: YK JK TS HK. Wrote the paper: YK JK NK HK.","The authors have the following interests. Yoshifumi Kotani, Ikutaro Sato, Takao Saito, Masamichi Toba, and Noriyuki Kohda are employed by Otsuka Phrmaceutical Co., Ltd., the funder of this study and provider of the lactic acid bacteria strain. Masamichi Toba is inventor on a patent WO2005019438 A1. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Yoshifumi Kotani","YK",8,TRUE,6,4,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
